Skip to main content
Premium Trial:

Request an Annual Quote

Swelling R&D Doubles Deltagen s Net Loss in Q4 Despite Strong Sales

NEW YORK, Feb. 13 - Deltagen on Tuesday posted strong growth in revenue in the fourth quarter although a surge in R&D spending doubled its net loss year over year.

 

For the period ended Dec. 31, Deltagen said that strong sales of its DeltaBase gene function database helped generate $2.5 million in total revenue compared with $1.3 million one year ago.

 

R&D spending in the quarter, which clocked in at $13.3 million compared with $6.8 million in the year-ago period, helped swell overall expenses to nearly $18 million compared with almost $11 million last year.

 

As a result, Deltagen posted a net loss of $15 million, or $.48 per share, in the current quarter compared with $7.5 million, or $.26 per share, last year.

 

The Redwood City, Calif.-based company said it had $76.5 million in the bank as of Dec. 31.

 

On Monday, Deltagen said it intends to acquire Bristol-Myers Squibb's Pharma Research Labs division for approximately $23.5 million in stock. The deal, which would give Deltagen the keys to a fully functioning small molecule-drug discovery firm, "will significantly advance Deltagen's efforts in using its validated targets for identifying lead candidate compounds for drug development," the company had said.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.